Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Peter Siegl"'
Autor:
Paul M. O’Neill, Richard K. Amewu, Susan A. Charman, Sunil Sabbani, Nina F. Gnädig, Judith Straimer, David A. Fidock, Emma R. Shore, Natalie L. Roberts, Michael H.-L. Wong, W. David Hong, Chandrakala Pidathala, Chris Riley, Ben Murphy, Ghaith Aljayyoussi, Francisco Javier Gamo, Laura Sanz, Janneth Rodrigues, Carolina Gonzalez Cortes, Esperanza Herreros, Iñigo Angulo-Barturén, María Belén Jiménez-Díaz, Santiago Ferrer Bazaga, María Santos Martínez-Martínez, Brice Campo, Raman Sharma, Eileen Ryan, David M. Shackleford, Simon Campbell, Dennis A. Smith, Grennady Wirjanata, Rintis Noviyanti, Ric N. Price, Jutta Marfurt, Michael J. Palmer, Ian M. Copple, Amy E. Mercer, Andrea Ruecker, Michael J. Delves, Robert E. Sinden, Peter Siegl, Jill Davies, Rosemary Rochford, Clemens H. M. Kocken, Anne-Marie Zeeman, Gemma L. Nixon, Giancarlo A. Biagini, Stephen A. Ward
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Artemisinin-resistantPlasmodium is an increasing problem. Here, using a medicinal chemistry programme, the authors identify a tetraoxane-based drug candidate that shows no cross-resistance with an artemisinin-resistant strain (PfK13-C580Y) and is eff
Externí odkaz:
https://doaj.org/article/d0b09995908d4fd1a466aa398f702f2f
Autor:
Tanya Paquet, David A. Fidock, Efrem Abay, Iñigo Angulo-Barturen, Kigbafori D. Silué, Diego Gonzàlez Cabrera, Mathew Njoroge, Leslie J. Street, Rintis Noviyanti, Karen L. White, Grennady Wirjanata, Cristina Donini, Michael J Witty, Nina Lawrence, Dalu Mancama, Lyn-Marie Birkholtz, Claire Le Manach, Sergio Wittlin, Ric N. Price, María Belén Jiménez-Díaz, Lubbe Wiesner, Jutta Marfurt, Didier Leroy, David Waterson, Peter Siegl, Christel Brunschwig, Paul V. Fish, Aloysius T. Nchinda, Manu Vanaerschot, Jacob A. McPhail, Mariëtte van der Watt, Dale Taylor, Susan A. Charman, Gregory S. Basarab, Carmen de Kock, Esperanza Herreros, John E. Burke, Suresh Solapure, Kennan C. Marsh, Francisco-Javier Gamo, Kelly Chibale, Theresa L. Coetzer, James Duffy, Rosemary Rochford, Janette Reader, Paolo Denti, Dennis A. Smith, Benjamin Blasco
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Autor:
Dalu Mancama, Lyn-Marie Birkholtz, Theresa L. Coetzer, Rosemary Rochford, Lubbe Wiesner, Janette Reader, Paolo Denti, Leslie J. Street, Dennis A. Smith, Benjamin Blasco, Rintis Noviyanti, Diego Gonzàlez Cabrera, Kennan C. Marsh, Francisco-Javier Gamo, David A. Fidock, Claire Le Manach, David Waterson, Paul V. Fish, Michael J Witty, Grennady Wirjanata, María Belén Jiménez-Díaz, Nina Lawrence, Jutta Marfurt, Dale Taylor, Mathew Njoroge, Christel Brunschwig, Manu Vanaerschot, Susan A. Charman, Cristina Donini, Didier Leroy, Ric N. Price, John E. Burke, Kelly Chibale, Iñigo Angulo-Barturen, Sergio Wittlin, Mariëtte van der Watt, James Duffy, Aloysius T. Nchinda, Peter Siegl, Suresh Solapure, Carmen de Kock, Karen L. White, Kigbafori D. Silué, Jacob A. McPhail, Gregory S. Basarab, Esperanza Herreros, Efrem Abay, Tanya Paquet
The 2-aminopyridine MMV048 was the first drug candidate inhibiting; Plasmodium; phosphatidylinositol 4-kinase (PI4K), a novel drug target for malaria, to enter clinical development. In an effort to identify the next generation of PI4K inhibitors, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c5ffba5560db512a6cc49ef66c9894e
https://ora.ox.ac.uk/objects/uuid:14edbcdb-ccd5-434f-ac7a-4c93ad57a0d7
https://ora.ox.ac.uk/objects/uuid:14edbcdb-ccd5-434f-ac7a-4c93ad57a0d7
Autor:
Peter Siegl, Stephen Toovey, Fiona Macintyre, Bart Laurijssens, Georg Ferber, Stephan Duparc, Borje Darpo
Publikováno v:
British Journal of Clinical Pharmacology
Aims The aim was to investigate the QT effect of a single dose combination regimen of piperaquine phosphate (PQP) and a novel aromatic trioxolane, OZ439, for malaria treatment. Methods Exposure–response (ER) analysis was performed on data from a pl
Publikováno v:
Stomatologie. 107:1-7
Im Teil 1 dieser Artikelserie wurde beschrieben, welche grundsatzlichen Moglichkeiten bei der Analyse des menschlichen Kauens mit Hilfe der Condylographie bestehen. Dabei wurde anhand von exemplarischen Fallstudien prasentiert, dass deutliche individ
Publikováno v:
Advances in Bioscience and Biotechnology. :68-78
The aim of this paper is to describe the possibilities of analyzing human mastication. The development of a standardized food model is presented. Based on the findings of a systematic literature search an elastic food model was created with the aim o
Publikováno v:
Stomatologie. 106:119-129
Die Untersuchung der menschlichen Kaufunktion ist derzeit nicht Bestandteil der klinischen Untersuchungen und findet auch keine Berucksichtigung in Therapie und Behandlungsplan. Dies ist umso mehr bemerkenswert, da die Kaufunktion eine essentielle is
Autor:
Beatriz, Baragaña, Irene, Hallyburton, Marcus C S, Lee, Neil R, Norcross, Raffaella, Grimaldi, Thomas D, Otto, William R, Proto, Andrew M, Blagborough, Stephan, Meister, Grennady, Wirjanata, Andrea, Ruecker, Leanna M, Upton, Tara S, Abraham, Mariana J, Almeida, Anupam, Pradhan, Achim, Porzelle, Torsten, Luksch, María Santos, Martínez, Judith M, Bolscher, Andrew, Woodland, Suzanne, Norval, Fabio, Zuccotto, John, Thomas, Frederick, Simeons, Laste, Stojanovski, Maria, Osuna-Cabello, Paddy M, Brock, Tom S, Churcher, Katarzyna A, Sala, Sara E, Zakutansky, María Belén, Jiménez-Díaz, Laura Maria, Sanz, Jennifer, Riley, Rajshekhar, Basak, Michael, Campbell, Vicky M, Avery, Robert W, Sauerwein, Koen J, Dechering, Rintis, Noviyanti, Brice, Campo, Julie A, Frearson, Iñigo, Angulo-Barturen, Santiago, Ferrer-Bazaga, Francisco Javier, Gamo, Paul G, Wyatt, Didier, Leroy, Peter, Siegl, Michael J, Delves, Dennis E, Kyle, Sergio, Wittlin, Jutta, Marfurt, Ric N, Price, Robert E, Sinden, Elizabeth A, Winzeler, Susan A, Charman, Lidiya, Bebrevska, David W, Gray, Simon, Campbell, Alan H, Fairlamb, Paul A, Willis, Julian C, Rayner, David A, Fidock, Kevin D, Read, Ian H, Gilbert
Publikováno v:
Nature, 522, 315-20
Nature, 522, 7556, pp. 315-20
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Nature, 522, 7556, pp. 315-20
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Contains fulltext : 155278.pdf (Publisher’s version ) (Closed access) There is an urgent need for new drugs to treat malaria, with broad therapeutic potential and novel modes of action, to widen the scope of treatment and to overcome emerging drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::650155b8830359ee22f2a3f3f91f5354
https://doi.org/10.1038/nature14451
https://doi.org/10.1038/nature14451
Autor:
Peter Siegl, Michael J. Delves, Matthew Berriman, Iñigo Angulo-Barturen, Vicky M. Avery, Boni F. Sebayang, Advait Nagle, Kiaran Kirk, Zhongsheng Zhang, Francisco-Javier Gamo, Matthew Wyvratt, Santiago Ferrer, Natalie J. Spillman, Jeremy N. Burrows, Marcin Stasiak, Joanne M. Morrisey, Thomas D. Otto, María Belén Jiménez-Díaz, Akhil B. Vaidya, Erkang Fan, María Santos Martínez, Jutta Marfurt, Grennady Wirjanata, Susan A. Charman, Thomas M. Daly, Sudipta Das, Arnab K. Chatterjee, Ric N. Price, Andrea Ruecker, Sandhya Kortagere, Lawrence W. Bergman
Publikováno v:
Nature Communications
The quest for new antimalarial drugs, especially those with novel modes of action, is essential in the face of emerging drug-resistant parasites. Here we describe a new chemical class of molecules, pyrazoleamides, with potent activity against human m
Autor:
Jessica Anne Steuten, Santiago Ferrer, Jeremy N. Burrows, Sandra Duffy, R. Matthew Cross, Rintis Noviyanti, Robert E. Sinden, Joanne M. Morrisey, Susan A. Charman, R. Kiplin Guy, Akhil B. Vaidya, Francisco-Javier Gamo, María Belén Jiménez-Díaz, Jutta Marfurt, Yuexin Li, Isaac P. Forquer, Jane X. Kelly, Dennis E. Kyle, Clemens H. M. Kocken, Peter Siegl, Laura M. Sanz, Roman Manetsch, Michael W. Mather, Ian Bathurst, Anne-Marie Zeeman, Vicky M. Avery, Eileen Ryan, Karen L. White, David M. Shackleford, Esperanza Herreros, Fabián E. Sáenz, Michael J. Delves, Michael K. Riscoe, Alexis N. LaCrue, Boni F. Sebayang, Iñigo Angulo-Barturen, Aaron Nilsen, Tina Mutka, Grennady Wirjanata, Ric N. Price, Rolf W. Winter
Publikováno v:
Science translational medicine
The goal for developing new antimalarial drugs is to find a molecule that can target multiple stages of the parasite's life cycle, thus impacting prevention, treatment, and transmission of the disease. The 4(1H)-quinolone-3-diarylethers are selective